METHODS FOR CULTURING DERMAL CELLS FOR TREATMENT OF SKIN INJURIES SUCH AS BURNS
The present invention relates to novel methods of growing or otherwise producing unpassaged or minimally passaged dermal cells from a small biopsy specimen for treating skin injuries significantly larger than the biopsy.
1 . A method of generating at least 60 million dermal cells from a small biopsy specimen, comprising the steps of:
a) grinding the small biopsy specimen with a micro tissue grinder to form a ground specimen;
b) digesting the ground specimen with a dissociative or digestive enzyme to form a cell suspension; and
c) harvesting the dermal cells from the cell suspension.
2 . The method of claim 1 wherein the enzyme is a collagenase.
3 . The method of claim 2 , wherein the collagenase is liberase.
4 . The method of claim 1 , wherein the enzyme is trypsin.
5 . The method of claim 1 , wherein at least 200 million minimally-passaged dermal cells are generated.
6 . A method of generating at least 60 million dermal cells from a small biopsy specimen, comprising the steps of:
a) grinding the small biopsy specimen with a micro tissue grinder to form a ground specimen;
b) digesting the ground specimen with a dissociative or digestive enzyme to form a cell suspension;
c) culturing the cells in the cell suspension for a period from 3 to 10 days; and
d) harvesting the dermal cells.
7 . The method of claim 1 , wherein at least 300 million minimally-passaged dermal cells are generated.
8 . The method of claim 1 , wherein at least 600 million minimally-passaged dermal cells are generated.
9 . The method of claim 1 , wherein the dermal cells have not been passaged.
10 . The method of claim 1 , wherein the dermal cells have been, passaged no more than one time.
11 . A method of treating a skin injury in an animal, comprising the step of administering to the animal the minimally-passaged dermal cells.
12 . The method of claim 11 wherein, the skin injury is a burn.
13 . The method of claim 11 , wherein one or more administrations each comprises between 10 and 600 million minimally-passaged dermal cells.
14 . The method of claim 12 , wherein the route of administration is injection into the burn area or area subadjacent to the burn,
15 . The method of claim 12 , wherein the route of administration is topical application.
16 . A composition comprising the minimally passaged dermal cells produced by the method of any of claims 1 - 10 claim 1 .
17 . A composition comprising conditioned method produced by the method of any of claims 1 - 10 claim 1 .